Clik here to view.
和铂医药完成B轮融资8500万美元 加速创新产品线研发
中国上海、荷兰鹿特丹、美国马萨诸塞州剑桥 和铂医药今天宣布成功完成B轮融资8500万美元，以加速公司创新产品线的成长，尤其是公司临床阶段项目及临床前项目的快速推进。本轮融资由新加坡政府投资公司GIC领投，国寿大健康基金、祥峰投资参与，A轮投资机构尚珹资本与君联资本跟投。...
View ArticleClik here to view.
Harbour BioMed Raises $85 Million in Series B Financing to Accelerate Its...
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today that it has completed a Series B round financing of $85 million to accelerate the growth of its...
View ArticleClik here to view.
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug...
HONG KONG & NEW YORK Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today...
View ArticleClik here to view.
Geneious Desktop Software to Be Renamed to Geneious Prime
AUCKLAND, New Zealand Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year....
View ArticleClik here to view.
Illumina的MiSeq™Dx系统在中国获得核准
圣迭戈 (美国商业资讯) — Illumina, Inc. (NASDAQ:ILMN)今天宣布，其MiSeq™Dx测序系统获得中国国家药品监督管理局(CNDA)核准。这是Illumina首款获得CNDA核准的下一代测序(NGS)系统。获得该核准后，Illumina现在可以向全中国的医院和其他医疗机构推广和销售MiSeqDx测序系统，用于体外诊断(IVD)检测。...
View ArticleClik here to view.
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
SAN FRANCISCO & BOSTON Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the...
View ArticleClik here to view.
Shionogi Announces U.S. Availability of Mulpleta® (Lusutrombopag) for the...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) announced today that Mulpleta® (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin...
View ArticleClik here to view.
PolyActiva Commences Its First Phase I Clinical Trial with Potential to...
MELBOURNE, Australia PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma...
View ArticleClik here to view.
Nebula Genomics从领先的技术和生物技术风投公司筹集430万美元种子经费
旧金山和波士顿 (美国商业资讯) — Nebula Genomics今天宣布已从10家领先的风投公司筹集430万美元种子经费。该经费将支持公司的使命，即创建一个值得信赖的、安全的、去中央化基因组数据市场，引领个人基因组测序的纪元。公司同时已与领先的全基因组测序和解读公司Veritas Genetics铸就伙伴关系，后者将把Nebula市场与Veritas的Arvados开源软件平台联接起来。...
View ArticleClik here to view.
NanOlogy™发布吸入NanoPac治疗肺癌的阳性临床前数据
德克萨斯州沃思堡和达拉斯 (美国商业资讯) — 临床阶段药品开发公司NanOlogy LLC呈报了吸入NanoPac™（亚微米颗粒紫杉醇）的临床前研究数据，非小细胞肺癌(NSCLC)原位动物模型显示，药物在肺组织中的驻留时间延长，肿瘤消退显著，未观察到药物相关的不良反应。在6月召开的ASCO 2018年会期间，该数据以摘要形式呈报，题为“NanoPac吸入治疗裸鼠原位肺癌模型的NSCLC”。...
View ArticleClik here to view.
SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived...
TOKYO The SanBio Group, a scientific leader in regenerative medicine for neurological disorders, today announced the acquisition of a patent portfolio regarding cell medicines derived from...
View ArticleClik here to view.
NovellusDx and Primetech Sign an Exclusive Dealer Agreement in Japan
TOKYO & JERUSALEM NovellusDx, Ltd. (CEO: Haim Gil-Ad, headquarters: Jerusalem Bio-Park, Hadassah medical center, Ein-Kerem Campus, Israel) and Primetech Co., Ltd. (President: Ryosuke Ogihara,...
View ArticleClik here to view.
Shionogi Announces Upcoming Presentations from Symproic® (naldemedine)...
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) will present four scientific posters featuring pre-clinical and clinical findings of Symproic® (naldemedine)...
View ArticleClik here to view.
ネビュラ・ゲノミクスが大手テクノロジー／バイオテクノロジーベンチャーキャピタルからシードファイナンスで430万ドルを調達
サンフランシスコ & ボストン （ビジネスワイヤ） —...
View ArticleClik here to view.
Minomic在美国和中国获得关键专利
悉尼 (美国商业资讯) — Minomic International Ltd (Minomic)是一家专攻实体瘤诊断及治疗商业化及开发的免疫肿瘤学公司，这些实体瘤包括前列腺癌、膀胱癌和胰腺癌。该公司宣布，其“诊断用细胞表面前列腺癌抗原”已获得美国和中国这两个全球关键市场的专利核准。...
View ArticleClik here to view.
New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy,...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared...
View ArticleClik here to view.
新研究比较两种指导目标导向补液治疗的方法：无创Masimo PVi®和侵入性食管多普勒超声
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，《BMC麻醉学》(BMC Anesthesiology)最新发表了瑞典林彻平大学医院的一项研究成果，研究人员比较了两种目标导向补液治疗(GDFT)方法对开腹大手术患者的功效，一是采用侵入性食管多普勒超声，另一种是采用Masimo...
View ArticleClik here to view.
BeiGene and SpringWorks Therapeutics Enter into Global Clinical Collaboration...
CAMBRIDGE, Mass. & BEIJING & NEW YORK BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
View ArticleClik here to view.
Swiss Advanced Vision上市Harmonis – 首款用于白内障手术的可定制EDOF人工晶体
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision...
View ArticleClik here to view.
Swiss Advanced Visionが初のカスタマイズ可能な白内障手術用EDOF IOLとなるHarmonisを発表
スイス・ヌーシャテル （ビジネスワイヤ） — Swiss Advanced...
View Article